"Congruence secures $32m in funds for genetic obesity drug trial" was originally created and published by Clinical Trials ...

Hendrix Genetics is accelerating the genetic engine of its turkey breeding program with a multi-year, EUR10 million (US$11.65 million) investment in research and development.

A nonprofit led by Anne Wojcicki, the co-founder and former chief executive of 23andMe, won a bid to acquire the genetic testing company following its bankruptcy filing in March. Wojcicki’s California ...